LAPINJECT VHD
LAPINJECT VHD
Authorised
- Rabbit haemorrhagic disease virus, Inactivated
Product identification
Medicine name:
LAPINJECT VHD
LAPINJECT VHD
Active substance:
- Rabbit haemorrhagic disease virus, Inactivated
Target species:
-
Rabbit
-
Rabbit (for reproduction)
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabbit haemorrhagic disease virus, Inactivated1.00/100% protective dose1.00unit(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Rabbit
-
All relevant tissues0day
-
-
Rabbit (for reproduction)
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Package description:
- Pack of 1 glass vial (2,5 ml) of 5 doses
- Pack of 1 glass vial (100 ml) of 200 doses
- Pack of 10 glass vials (20 ml) of 40 doses
- Pack of 2 glass vials (20 ml) of 40 doses
- Pack of 1 glass vial (20 ml) of 40 doses
- Pack of 10 glass vials (10 ml) of 20 doses
- Pack of 1 glass vial (10 ml) of 20 doses
- Pack of 10 glass vials (5 ml) of 10 doses
- Pack of 1 glass vial (5 ml) of 10 doses
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Ceva Salute Animale S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- Ministry Of Health
Authorisation number:
- 103849
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0163/001
Concerned member states:
-
Italy
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
